Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Microbiome Therapeutics Market 2018, Forecast to 2023
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
Scope of the Report
This report focuses on the Microbiome Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The worldwide market for Microbiome Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Microbiome Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Microbiome Therapeutics, with sales, revenue, and price of Microbiome Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Microbiome Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
Scope of the Report
This report focuses on the Microbiome Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The worldwide market for Microbiome Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Type I
- Type II
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
Chapter 1, to describe Microbiome Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Microbiome Therapeutics, with sales, revenue, and price of Microbiome Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Microbiome Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Inflammatory Bowel Disease (IBD)
1.3.2 Orphan Drug
1.3.3 Immuno-oncology
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.1.1 Seres Therapeutics Description
2.1.1.2 Seres Therapeutics Headquarter, Main Business and Finance Overview
2.1.2 Seres Therapeutics Microbiome Therapeutics Product Introduction
2.1.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 Microbiome Therapeutics Product Information
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Seres Therapeutics Microbiome Therapeutics Market Share in 2017
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.1.1 Assembly Biosciences Description
2.2.1.2 Assembly Biosciences Headquarter, Main Business and Finance Overview
2.2.2 Assembly Biosciences Microbiome Therapeutics Product Introduction
2.2.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 Microbiome Therapeutics Product Information
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Assembly Biosciences Microbiome Therapeutics Market Share in 2017
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.1.1 Synthetic Biologics Description
2.3.1.2 Synthetic Biologics Headquarter, Main Business and Finance Overview
2.3.2 Synthetic Biologics Microbiome Therapeutics Product Introduction
2.3.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 Microbiome Therapeutics Product Information
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Synthetic Biologics Microbiome Therapeutics Market Share in 2017
2.4 Interxon
2.4.1 Business Overview
2.4.1.1 Interxon Description
2.4.1.2 Interxon Headquarter, Main Business and Finance Overview
2.4.2 Interxon Microbiome Therapeutics Product Introduction
2.4.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 Microbiome Therapeutics Product Information
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Interxon Microbiome Therapeutics Market Share in 2017
2.5 PureTech
2.5.1 Business Overview
2.5.1.1 PureTech Description
2.5.1.2 PureTech Headquarter, Main Business and Finance Overview
2.5.2 PureTech Microbiome Therapeutics Product Introduction
2.5.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 Microbiome Therapeutics Product Information
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global PureTech Microbiome Therapeutics Market Share in 2017
2.6 Synlogic
2.6.1 Business Overview
2.6.1.1 Synlogic Description
2.6.1.2 Synlogic Headquarter, Main Business and Finance Overview
2.6.2 Synlogic Microbiome Therapeutics Product Introduction
2.6.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 Microbiome Therapeutics Product Information
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Synlogic Microbiome Therapeutics Market Share in 2017
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.1.1 Enterome BioScience Description
2.7.1.2 Enterome BioScience Headquarter, Main Business and Finance Overview
2.7.2 Enterome BioScience Microbiome Therapeutics Product Introduction
2.7.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 Microbiome Therapeutics Product Information
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Enterome BioScience Microbiome Therapeutics Market Share in 2017
2.8 4D Pharma
2.8.1 Business Overview
2.8.1.1 4D Pharma Description
2.8.1.2 4D Pharma Headquarter, Main Business and Finance Overview
2.8.2 4D Pharma Microbiome Therapeutics Product Introduction
2.8.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 Microbiome Therapeutics Product Information
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global 4D Pharma Microbiome Therapeutics Market Share in 2017
2.9 Second Genome
2.9.1 Business Overview
2.9.1.1 Second Genome Description
2.9.1.2 Second Genome Headquarter, Main Business and Finance Overview
2.9.2 Second Genome Microbiome Therapeutics Product Introduction
2.9.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 Microbiome Therapeutics Product Information
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Second Genome Microbiome Therapeutics Market Share in 2017
2.10 AOBiome
2.10.1 Business Overview
2.10.1.1 AOBiome Description
2.10.1.2 AOBiome Headquarter, Main Business and Finance Overview
2.10.2 AOBiome Microbiome Therapeutics Product Introduction
2.10.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 Microbiome Therapeutics Product Information
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AOBiome Microbiome Therapeutics Market Share in 2017
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 C3 Jian Microbiome Therapeutics Product Introduction
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Rebiotix Microbiome Therapeutics Product Introduction
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Introduction
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Metabiomics Microbiome Therapeutics Product Introduction
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Introduction
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Symberix Microbiome Therapeutics Product Introduction
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 OpenBiome Microbiome Therapeutics Product Introduction
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Azitra Microbiome Therapeutics Product Introduction
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Introduction
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Osel Microbiome Therapeutics Product Introduction
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.21.2 Metabogen Microbiome Therapeutics Product Introduction
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL MICROBIOME THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY REGIONS
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Microbiome Therapeutics Revenue by Regions (2013-2018)
4.2 North America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Microbiome Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Microbiome Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Microbiome Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Microbiome Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Microbiome Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Microbiome Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Microbiome Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Microbiome Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MICROBIOME THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2013-2018)
10.2.2 Global Type I Price (2013-2018)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2013-2018)
10.3.2 Global Type II Price (2013-2018)
11 GLOBAL MICROBIOME THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.2 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
11.3 Orphan Drug Sales Growth (2013-2018)
11.4 Immuno-oncology Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 MICROBIOME THERAPEUTICS MARKET FORECAST (2018-2023)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Microbiome Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2018-2023)
12.2.4 South America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2018-2023)
12.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Inflammatory Bowel Disease (IBD)
1.3.2 Orphan Drug
1.3.3 Immuno-oncology
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.1.1 Seres Therapeutics Description
2.1.1.2 Seres Therapeutics Headquarter, Main Business and Finance Overview
2.1.2 Seres Therapeutics Microbiome Therapeutics Product Introduction
2.1.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 Microbiome Therapeutics Product Information
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Seres Therapeutics Microbiome Therapeutics Market Share in 2017
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.1.1 Assembly Biosciences Description
2.2.1.2 Assembly Biosciences Headquarter, Main Business and Finance Overview
2.2.2 Assembly Biosciences Microbiome Therapeutics Product Introduction
2.2.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 Microbiome Therapeutics Product Information
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Assembly Biosciences Microbiome Therapeutics Market Share in 2017
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.1.1 Synthetic Biologics Description
2.3.1.2 Synthetic Biologics Headquarter, Main Business and Finance Overview
2.3.2 Synthetic Biologics Microbiome Therapeutics Product Introduction
2.3.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 Microbiome Therapeutics Product Information
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Synthetic Biologics Microbiome Therapeutics Market Share in 2017
2.4 Interxon
2.4.1 Business Overview
2.4.1.1 Interxon Description
2.4.1.2 Interxon Headquarter, Main Business and Finance Overview
2.4.2 Interxon Microbiome Therapeutics Product Introduction
2.4.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 Microbiome Therapeutics Product Information
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Interxon Microbiome Therapeutics Market Share in 2017
2.5 PureTech
2.5.1 Business Overview
2.5.1.1 PureTech Description
2.5.1.2 PureTech Headquarter, Main Business and Finance Overview
2.5.2 PureTech Microbiome Therapeutics Product Introduction
2.5.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 Microbiome Therapeutics Product Information
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global PureTech Microbiome Therapeutics Market Share in 2017
2.6 Synlogic
2.6.1 Business Overview
2.6.1.1 Synlogic Description
2.6.1.2 Synlogic Headquarter, Main Business and Finance Overview
2.6.2 Synlogic Microbiome Therapeutics Product Introduction
2.6.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 Microbiome Therapeutics Product Information
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Synlogic Microbiome Therapeutics Market Share in 2017
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.1.1 Enterome BioScience Description
2.7.1.2 Enterome BioScience Headquarter, Main Business and Finance Overview
2.7.2 Enterome BioScience Microbiome Therapeutics Product Introduction
2.7.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 Microbiome Therapeutics Product Information
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Enterome BioScience Microbiome Therapeutics Market Share in 2017
2.8 4D Pharma
2.8.1 Business Overview
2.8.1.1 4D Pharma Description
2.8.1.2 4D Pharma Headquarter, Main Business and Finance Overview
2.8.2 4D Pharma Microbiome Therapeutics Product Introduction
2.8.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 Microbiome Therapeutics Product Information
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global 4D Pharma Microbiome Therapeutics Market Share in 2017
2.9 Second Genome
2.9.1 Business Overview
2.9.1.1 Second Genome Description
2.9.1.2 Second Genome Headquarter, Main Business and Finance Overview
2.9.2 Second Genome Microbiome Therapeutics Product Introduction
2.9.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 Microbiome Therapeutics Product Information
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Second Genome Microbiome Therapeutics Market Share in 2017
2.10 AOBiome
2.10.1 Business Overview
2.10.1.1 AOBiome Description
2.10.1.2 AOBiome Headquarter, Main Business and Finance Overview
2.10.2 AOBiome Microbiome Therapeutics Product Introduction
2.10.2.1 Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 Microbiome Therapeutics Product Information
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AOBiome Microbiome Therapeutics Market Share in 2017
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 C3 Jian Microbiome Therapeutics Product Introduction
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Rebiotix Microbiome Therapeutics Product Introduction
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Introduction
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Metabiomics Microbiome Therapeutics Product Introduction
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Introduction
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Symberix Microbiome Therapeutics Product Introduction
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 OpenBiome Microbiome Therapeutics Product Introduction
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Azitra Microbiome Therapeutics Product Introduction
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Introduction
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Osel Microbiome Therapeutics Product Introduction
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.21.2 Metabogen Microbiome Therapeutics Product Introduction
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL MICROBIOME THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY REGIONS
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Microbiome Therapeutics Revenue by Regions (2013-2018)
4.2 North America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Microbiome Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Microbiome Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Microbiome Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Microbiome Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Microbiome Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Microbiome Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Microbiome Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MICROBIOME THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Microbiome Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MICROBIOME THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2013-2018)
10.2.2 Global Type I Price (2013-2018)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2013-2018)
10.3.2 Global Type II Price (2013-2018)
11 GLOBAL MICROBIOME THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.2 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
11.3 Orphan Drug Sales Growth (2013-2018)
11.4 Immuno-oncology Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 MICROBIOME THERAPEUTICS MARKET FORECAST (2018-2023)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Microbiome Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2018-2023)
12.2.4 South America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2018-2023)
12.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2017
Figure Type I Picture
Table Major Manufacturers of Type I
Figure Type II Picture
Table Major Manufacturers of Type II
Figure Microbiome Therapeutics Sales Market Share by Applications in 2017
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Seres Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Seres Therapeutics Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Seres Therapeutics Microbiome Therapeutics Product
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Seres Therapeutics Microbiome Therapeutics Sales Market Share in 2017
Figure Global Seres Therapeutics Microbiome Therapeutics Revenue Market Share in 2017
Table Assembly Biosciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Assembly Biosciences Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Assembly Biosciences Microbiome Therapeutics Product
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Assembly Biosciences Microbiome Therapeutics Sales Market Share in 2017
Figure Global Assembly Biosciences Microbiome Therapeutics Revenue Market Share in 2017
Table Synthetic Biologics Headquarter, Established, Main Business and Finance Overview (2017)
Table Synthetic Biologics Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Synthetic Biologics Microbiome Therapeutics Product
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Synthetic Biologics Microbiome Therapeutics Sales Market Share in 2017
Figure Global Synthetic Biologics Microbiome Therapeutics Revenue Market Share in 2017
Table Interxon Headquarter, Established, Main Business and Finance Overview (2017)
Table Interxon Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Interxon Microbiome Therapeutics Product
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Interxon Microbiome Therapeutics Sales Market Share in 2017
Figure Global Interxon Microbiome Therapeutics Revenue Market Share in 2017
Table PureTech Headquarter, Established, Main Business and Finance Overview (2017)
Table PureTech Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table PureTech Microbiome Therapeutics Product
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global PureTech Microbiome Therapeutics Sales Market Share in 2017
Figure Global PureTech Microbiome Therapeutics Revenue Market Share in 2017
Table Synlogic Headquarter, Established, Main Business and Finance Overview (2017)
Table Synlogic Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Synlogic Microbiome Therapeutics Product
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Synlogic Microbiome Therapeutics Sales Market Share in 2017
Figure Global Synlogic Microbiome Therapeutics Revenue Market Share in 2017
Table Enterome BioScience Headquarter, Established, Main Business and Finance Overview (2017)
Table Enterome BioScience Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Enterome BioScience Microbiome Therapeutics Product
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Enterome BioScience Microbiome Therapeutics Sales Market Share in 2017
Figure Global Enterome BioScience Microbiome Therapeutics Revenue Market Share in 2017
Table 4D Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table 4D Pharma Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table 4D Pharma Microbiome Therapeutics Product
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global 4D Pharma Microbiome Therapeutics Sales Market Share in 2017
Figure Global 4D Pharma Microbiome Therapeutics Revenue Market Share in 2017
Table Second Genome Headquarter, Established, Main Business and Finance Overview (2017)
Table Second Genome Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Second Genome Microbiome Therapeutics Product
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Second Genome Microbiome Therapeutics Sales Market Share in 2017
Figure Global Second Genome Microbiome Therapeutics Revenue Market Share in 2017
Table AOBiome Headquarter, Established, Main Business and Finance Overview (2017)
Table AOBiome Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table AOBiome Microbiome Therapeutics Product
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AOBiome Microbiome Therapeutics Sales Market Share in 2017
Figure Global AOBiome Microbiome Therapeutics Revenue Market Share in 2017
Table C3 Jian
Table C3 Jian Microbiome Therapeutics
Table Rebiotix
Table Rebiotix Microbiome Therapeutics
Table MicroBiome Therapeutics LLC
Table MicroBiome Therapeutics LLC Microbiome Therapeutics
Table Metabiomics
Table Metabiomics Microbiome Therapeutics
Table Ritter Pharmaceuticals
Table Ritter Pharmaceuticals Microbiome Therapeutics
Table Symberix
Table Symberix Microbiome Therapeutics
Table OpenBiome
Table OpenBiome Microbiome Therapeutics
Table Azitra
Table Azitra Microbiome Therapeutics
Table Symbiotix Biotherapies
Table Symbiotix Biotherapies Microbiome Therapeutics
Table Osel
Table Osel Microbiome Therapeutics
Table Metabogen
Table Metabogen Microbiome Therapeutics
Table Global Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Microbiome Therapeutics Sales by Regions (2013-2018)
Table Global Microbiome Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Microbiome Therapeutics Revenue by Regions (2013-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2013
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2017
Figure North America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales by Countries (2013-2018)
Table North America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table North America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Sales by Type (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table North America Microbiome Therapeutics Sales by Application (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Application (2013-2018)
Table North America Microbiome Therapeutics Revenue by Application (2013-2018)
Table North America Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Microbiome Therapeutics Sales by Countries (2013-2018)
Table Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Europe Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Europe Microbiome Therapeutics Sales by Type (2013-2018)
Table Europe Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Type (2013-2018)
Table Europe Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Europe Microbiome Therapeutics Sales by Application (2013-2018)
Table Europe Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Application (2013-2018)
Table Europe Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries 2017
Figure China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Microbiome Therapeutics Sales by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Microbiome Therapeutics Sales by Countries (2013-2018)
Table South America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table South America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table South America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table South America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure South America Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure South America Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table South America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure South America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure South America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table South America Microbiome Therapeutics Sales by Type (2013-2018)
Table South America Microbiome Therapeutics Sales Share by Type (2013-2018)
Table South America Microbiome Therapeutics Revenue by Type (2013-2018)
Table South America Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table South America Microbiome Therapeutics Sales by Application (2013-2018)
Table South America Microbiome Therapeutics Sales Share by Application (2013-2018)
Table South America Microbiome Therapeutics Revenue by Application (2013-2018)
Table South America Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Microbiome Therapeutics Sales by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Share by Application (2013-2018)
Table Global Microbiome Therapeutics Sales by Type (2013-2018)
Table Global Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue Share by Type (2013-2018)
Figure Global Type I Sales Growth (2013-2018)
Figure Global Type I Price (2013-2018)
Figure Global Type II Sales Growth (2013-2018)
Figure Global Type II Price (2013-2018)
Table Global Microbiome Therapeutics Sales by Application (2013-2018)
Table Global Microbiome Therapeutics Sales Share by Application (2013-2018)
Figure Global Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure Global Orphan Drug Sales Growth (2013-2018)
Figure Global Immuno-oncology Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure South America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Microbiome Therapeutics Market Forecast (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2017
Figure Type I Picture
Table Major Manufacturers of Type I
Figure Type II Picture
Table Major Manufacturers of Type II
Figure Microbiome Therapeutics Sales Market Share by Applications in 2017
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Seres Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Seres Therapeutics Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Seres Therapeutics Microbiome Therapeutics Product
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Seres Therapeutics Microbiome Therapeutics Sales Market Share in 2017
Figure Global Seres Therapeutics Microbiome Therapeutics Revenue Market Share in 2017
Table Assembly Biosciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Assembly Biosciences Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Assembly Biosciences Microbiome Therapeutics Product
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Assembly Biosciences Microbiome Therapeutics Sales Market Share in 2017
Figure Global Assembly Biosciences Microbiome Therapeutics Revenue Market Share in 2017
Table Synthetic Biologics Headquarter, Established, Main Business and Finance Overview (2017)
Table Synthetic Biologics Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Synthetic Biologics Microbiome Therapeutics Product
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Synthetic Biologics Microbiome Therapeutics Sales Market Share in 2017
Figure Global Synthetic Biologics Microbiome Therapeutics Revenue Market Share in 2017
Table Interxon Headquarter, Established, Main Business and Finance Overview (2017)
Table Interxon Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Interxon Microbiome Therapeutics Product
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Interxon Microbiome Therapeutics Sales Market Share in 2017
Figure Global Interxon Microbiome Therapeutics Revenue Market Share in 2017
Table PureTech Headquarter, Established, Main Business and Finance Overview (2017)
Table PureTech Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table PureTech Microbiome Therapeutics Product
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global PureTech Microbiome Therapeutics Sales Market Share in 2017
Figure Global PureTech Microbiome Therapeutics Revenue Market Share in 2017
Table Synlogic Headquarter, Established, Main Business and Finance Overview (2017)
Table Synlogic Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Synlogic Microbiome Therapeutics Product
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Synlogic Microbiome Therapeutics Sales Market Share in 2017
Figure Global Synlogic Microbiome Therapeutics Revenue Market Share in 2017
Table Enterome BioScience Headquarter, Established, Main Business and Finance Overview (2017)
Table Enterome BioScience Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Enterome BioScience Microbiome Therapeutics Product
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Enterome BioScience Microbiome Therapeutics Sales Market Share in 2017
Figure Global Enterome BioScience Microbiome Therapeutics Revenue Market Share in 2017
Table 4D Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table 4D Pharma Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table 4D Pharma Microbiome Therapeutics Product
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global 4D Pharma Microbiome Therapeutics Sales Market Share in 2017
Figure Global 4D Pharma Microbiome Therapeutics Revenue Market Share in 2017
Table Second Genome Headquarter, Established, Main Business and Finance Overview (2017)
Table Second Genome Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table Second Genome Microbiome Therapeutics Product
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Second Genome Microbiome Therapeutics Sales Market Share in 2017
Figure Global Second Genome Microbiome Therapeutics Revenue Market Share in 2017
Table AOBiome Headquarter, Established, Main Business and Finance Overview (2017)
Table AOBiome Microbiome Therapeutics Production Bases, Sales Regions and Major Competitors
Table AOBiome Microbiome Therapeutics Product
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AOBiome Microbiome Therapeutics Sales Market Share in 2017
Figure Global AOBiome Microbiome Therapeutics Revenue Market Share in 2017
Table C3 Jian
Table C3 Jian Microbiome Therapeutics
Table Rebiotix
Table Rebiotix Microbiome Therapeutics
Table MicroBiome Therapeutics LLC
Table MicroBiome Therapeutics LLC Microbiome Therapeutics
Table Metabiomics
Table Metabiomics Microbiome Therapeutics
Table Ritter Pharmaceuticals
Table Ritter Pharmaceuticals Microbiome Therapeutics
Table Symberix
Table Symberix Microbiome Therapeutics
Table OpenBiome
Table OpenBiome Microbiome Therapeutics
Table Azitra
Table Azitra Microbiome Therapeutics
Table Symbiotix Biotherapies
Table Symbiotix Biotherapies Microbiome Therapeutics
Table Osel
Table Osel Microbiome Therapeutics
Table Metabogen
Table Metabogen Microbiome Therapeutics
Table Global Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Microbiome Therapeutics Sales by Regions (2013-2018)
Table Global Microbiome Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Microbiome Therapeutics Revenue by Regions (2013-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2013
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2017
Figure North America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales by Countries (2013-2018)
Table North America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table North America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Sales by Type (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table North America Microbiome Therapeutics Sales by Application (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Application (2013-2018)
Table North America Microbiome Therapeutics Revenue by Application (2013-2018)
Table North America Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Microbiome Therapeutics Sales by Countries (2013-2018)
Table Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Europe Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Europe Microbiome Therapeutics Sales by Type (2013-2018)
Table Europe Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Type (2013-2018)
Table Europe Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Europe Microbiome Therapeutics Sales by Application (2013-2018)
Table Europe Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Application (2013-2018)
Table Europe Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries 2017
Figure China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Microbiome Therapeutics Sales by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue by Application (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Microbiome Therapeutics Sales by Countries (2013-2018)
Table South America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table South America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table South America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table South America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure South America Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure South America Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table South America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure South America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure South America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table South America Microbiome Therapeutics Sales by Type (2013-2018)
Table South America Microbiome Therapeutics Sales Share by Type (2013-2018)
Table South America Microbiome Therapeutics Revenue by Type (2013-2018)
Table South America Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table South America Microbiome Therapeutics Sales by Application (2013-2018)
Table South America Microbiome Therapeutics Sales Share by Application (2013-2018)
Table South America Microbiome Therapeutics Revenue by Application (2013-2018)
Table South America Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Microbiome Therapeutics Sales by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Share by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue by Application (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Share by Application (2013-2018)
Table Global Microbiome Therapeutics Sales by Type (2013-2018)
Table Global Microbiome Therapeutics Sales Share by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue Share by Type (2013-2018)
Figure Global Type I Sales Growth (2013-2018)
Figure Global Type I Price (2013-2018)
Figure Global Type II Sales Growth (2013-2018)
Figure Global Type II Price (2013-2018)
Table Global Microbiome Therapeutics Sales by Application (2013-2018)
Table Global Microbiome Therapeutics Sales Share by Application (2013-2018)
Figure Global Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure Global Orphan Drug Sales Growth (2013-2018)
Figure Global Immuno-oncology Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure South America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Microbiome Therapeutics Market Forecast (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
